Skip to main content
Journal cover image

The devil is in the details: Assessing treatment and outcomes of 6,795 patients undergoing remedial parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program.

Publication ,  Journal Article
Kazaure, HS; Thomas, S; Scheri, RP; Stang, MT; Roman, SA; Sosa, JA
Published in: Surgery
January 2019

BACKGROUND: Multi-institutional data describing remedial parathyroidectomy compared with index parathyroidectomy are scarce. METHODS: Using data in the Collaborative Endocrine Surgery Quality Improvement Program (2014-2017), baseline characteristics and outcomes of patients undergoing remedial parathyroidectomy versus index parathyroidectomy were examined using bivariate and multivariate methods. Rates of hypercalcemia and hypocalcemia at ≥ 180 days were assessed. RESULTS: Among 6,795 patients, 367 (5.4%) underwent remedial parathyroidectomy. A single localization study was done in 24.8% versus 26.9% of remedial parathyroidectomy versus index parathyroidectomy (P = .37). Patients undergoing remedial parathyroidectomy had higher rates of preoperative laryngoscopy (45.5% versus 6.2%, P < .001), intraoperative nerve monitoring (57.5% versus 34.5%, P < .001), and < 50% drop in hyperparathyroidism than those undergoing index parathyroidectomy (9.6% versus 3.3%, P < .001). Among patients with ≥ 180 days follow-up, none of the remedial parathyroidectomy versus three index parathyroidectomy patients (0.3%) had vocal cord dysfunction. Hypercalcemia rates for remedial parathyroidectomy and index parathyroidectomy were 10.5% versus 5.0 (P = .07), and hypocalcemia rates were 10.5% versus 2.4% (P < .001). After multivariate adjustment, failure to cure was 4.0 times more likely in remedial parathyroidectomy than index parathyroidectomy (P < .001). CONCLUSION: This is the first multi-institutional examination of remedial parathyroidectomy outcomes in the Collaborative Endocrine Surgery Quality Improvement Program. Nerve injury rates are low; high rates of hypercalcemia and hypocalcemia suggest potential opportunities to refine the preoperative and intraoperative management of patients undergoing remedial parathyroidectomy.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Surgery

DOI

EISSN

1532-7361

Publication Date

January 2019

Volume

165

Issue

1

Start / End Page

242 / 249

Location

United States

Related Subject Headings

  • Vocal Cord Dysfunction
  • Treatment Outcome
  • Thymectomy
  • Surgery
  • Quality Improvement
  • Postoperative Complications
  • Parathyroidectomy
  • Parathyroid Glands
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kazaure, H. S., Thomas, S., Scheri, R. P., Stang, M. T., Roman, S. A., & Sosa, J. A. (2019). The devil is in the details: Assessing treatment and outcomes of 6,795 patients undergoing remedial parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program. Surgery, 165(1), 242–249. https://doi.org/10.1016/j.surg.2018.03.026
Kazaure, Hadiza S., Samantha Thomas, Randall P. Scheri, Michael T. Stang, Sanziana A. Roman, and Julie A. Sosa. “The devil is in the details: Assessing treatment and outcomes of 6,795 patients undergoing remedial parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program.Surgery 165, no. 1 (January 2019): 242–49. https://doi.org/10.1016/j.surg.2018.03.026.
Kazaure, Hadiza S., et al. “The devil is in the details: Assessing treatment and outcomes of 6,795 patients undergoing remedial parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program.Surgery, vol. 165, no. 1, Jan. 2019, pp. 242–49. Pubmed, doi:10.1016/j.surg.2018.03.026.
Journal cover image

Published In

Surgery

DOI

EISSN

1532-7361

Publication Date

January 2019

Volume

165

Issue

1

Start / End Page

242 / 249

Location

United States

Related Subject Headings

  • Vocal Cord Dysfunction
  • Treatment Outcome
  • Thymectomy
  • Surgery
  • Quality Improvement
  • Postoperative Complications
  • Parathyroidectomy
  • Parathyroid Glands
  • Middle Aged
  • Male